Shanghai Haohai Biological Technology Co., Ltd.
Shanghai Haohai Biological Technology Co., Ltd. (HKSE: 6826) is trading at HK$15.90, about ₹195 at today's HKD/INR rate, as of 30 Sep 2026, 3:59 AM ET, up 1.15% today. Indian residents can buy Shanghai Haohai Biological Technology from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$15.43
Today's high
HK$16.11
52 week low
HK$15.04
52 week high
HK$30.68
6826 opened at HK$15.79, closed previously at HK$15.72, and has traded between HK$15.04 and HK$30.68 over the past 52 weeks.
About
Shanghai Haohai Biological Technology Co., Ltd. is a global enterprise dedicated to the research, development, manufacturing, and commercialization of biomedical materials. Its operations span Mainland China, the United States, the United Kingdom, and various other international regions. A comprehensive product portfolio addresses several key medical disciplines. Within ophthalmology, offerings include intraocular lenses, ophthalmic viscoelastic devices, orthokeratology and phakic refractive lenses, eye drops, injectors, and surgical scalpels. Orthopedics products encompass sodium hyaluronate injections and medical chitosan. For wound repair, it manufactures recombinant human epidermal growth factor, effective in treating burn wounds, residual wounds, donor site post-traumatic wounds, and both fresh and chronic ulcerations. Additionally, the company develops anti-adhesion materials, including medical sodium hyaluronate gel and medical chitosan, as well as hemostatic solutions such as collagen sponges and porcine fibrin sealants. Beyond its therapeutic offerings, Shanghai Haohai maintains a significant presence in the medical aesthetics market. This segment features a range of hyaluronic acid (HA) dermal fillers: Matrifill, positioned as a first-generation mono-phase injectable HA gel; Janlane, a second-generation filler engineered for dynamic application; and Hyalumatrix, a third-generation product providing precise aesthetic embellishment. Its aesthetic portfolio is further complemented by radio frequency devices and laser equipment. Furthermore, the company actively engages in the research and development of biological engineering and pharmaceutical products, extending services such as technology transfer and consultation. It also conducts investment and trading operations. Established in 2007, the entity initially traded as Haohai Limited before officially adopting the name Shanghai Haohai Biological Technology Co., Ltd. in 2010. Its corporate headquarters are based in Shanghai, China.
Key statistics
Avg. volume
166.16K
Market cap
HK$6.39B
P/E Ratio
45.34
Price-to-sales ratio
2.46
Enterprise value
CN¥3.04B
Free cash flow yield
8.76%
Debt-to-equity ratio
0.08
Return on equity
4.51%
ROIC
3.15%
Beta
0.47
Dividend yield
2.14%
Last dividend
HK$1.13
Financial overview
Revenue
CN¥2.45B
Earnings per share
CN¥1.08
Free cash flow
CN¥446.40M
Net profit margin
6.50%
Gross margin
98.65%
EBITDA
CN¥418.16M
Revenue growth
-8.71%
Similar securities
This is not an investment recommendation
How to buy Shanghai Haohai Biological Technology from India
Indian residents can buy Shanghai Haohai Biological Technology shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Shanghai Haohai Biological Technology and place an order
Find Shanghai Haohai Biological Technology by name or by its ticker, 6826, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Shanghai Haohai Biological Technology trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Shanghai Haohai Biological Technology position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Shanghai Haohai Biological Technology from India
Trading and taxes when buying Shanghai Haohai Biological Technology from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Shanghai Haohai Biological Technology’s current yield is 2.14%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Shanghai Haohai Biological Technology stock?
Yes. Shanghai Haohai Biological Technology (6826) has been listed on the Hong Kong Stock Exchange since 2015, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Shanghai Haohai Biological Technology share cost in rupees?
One Shanghai Haohai Biological Technology share is HK$15.90 — about ₹195 at an HKD/INR rate of 12.24 on 29 Sep 2026. Both the Shanghai Haohai Biological Technology price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Shanghai Haohai Biological Technology from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Shanghai Haohai Biological Technology?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Shanghai Haohai Biological Technology shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Shanghai Haohai Biological Technology price. Paasa issues a capital-gains statement for your return.
Does Shanghai Haohai Biological Technology pay a dividend, and how is it taxed in India?
Yes. Shanghai Haohai Biological Technology pays a dividend and the current yield is 2.14%; the last declared dividend was HK$1.13 per share, about ₹13.79. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Shanghai Haohai Biological Technology from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Shanghai Haohai Biological Technology a Hong Kong SAR China company, and does that change how it is taxed?
Shanghai Haohai Biological Technology trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Shanghai Haohai Biological Technology trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Shanghai Haohai Biological Technology shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Shanghai Haohai Biological Technology holding, its cost and its closing value.
How do I sell Shanghai Haohai Biological Technology and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.